Series B - Novome Biotechnologies

Series B - Novome Biotechnologies

Investment Firm

Overview

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Announced Date

Sep 13, 2022

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorDCVC Bio
Participant InvestorUniversity of Minnesota
Participant InvestorAlta Partners
Participant Investor5AM Ventures
Participant InvestorTouchdown Ventures

Round Details and Background

Novome Biotechnologies raised $43500000 on 2022-09-13 in Series B

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 09, 2018
Seed Round - Novome Biotechnologies
1-4.5M
Aug 16, 2018
Grant - Novome Biotechnologies
1-1.3M
Dec 08, 2016
Grant - Novome Biotechnologies
1-225.0K
Sep 13, 2022
Series B - Novome Biotechnologies
8-43.5M

Recent Activity

There is no recent news or activity for this profile.